Allergy Therapeutics plc has been mentioned in a Form 8.5 (EPT/RI) disclosure by Panmure Gordon (UK) Limited. The disclosure states that Panmure Gordon (UK) Limited, as an exempt principal trader, has made purchases and sales of Allergy Therapeutics plc's 0.1p ordinary shares. The disclosure provides details of the number of securities bought and sold, as well as the highest and lowest prices per unit paid or received.
The disclosure does not mention any cash-settled derivative transactions or stock-settled derivative transactions, including options, related to Allergy Therapeutics plc's securities.
The disclosure also states that there are no indemnity or option arrangements, agreements, or understandings between Panmure Gordon (UK) Limited and any party to the offer or any person acting in concert with a party to the offer.
The contact information for the disclosure is provided as Lauren Riley, with a telephone number of 020 7886 2963.
Overall, the disclosure provides information about the trading activities of Panmure Gordon (UK) Limited in relation to Allergy Therapeutics plc's securities.